CytoMed Therapeutics Ltd（GDTC）適時開示・決算発表
| 提出日 | 様式 | 項目 | 原文 |
|---|---|---|---|
| 2026-06-23 | 6-K | — | SEC |
| 2026-06-03 | 6-K | — | SEC |
| 2026-05-15 | 6-K | — | SEC |
| 2026-05-11 | 6-K | — | SEC |
| 2026-04-14 | 6-K | — | SEC |
| 2026-03-31 | 6-K | — | SEC |
| 2026-01-28 | 6-K | — | SEC |
| 2026-01-13 | 6-K | — | SEC |
| 2025-12-08 | 6-K | — | SEC |
| 2025-11-18 | 6-K | — | SEC |
| 2025-11-06 | 6-K | — | SEC |
| 2025-10-22 | 6-K | — | SEC |
| 2025-10-14 | 6-K | — | SEC |
| 2025-10-02 | 6-K | — | SEC |
| 2025-09-30 | 6-K | — | SEC |
| 2025-08-28 | 6-K | — | SEC |
| 2025-08-19 | 6-K | — | SEC |
| 2025-07-21 | 6-K | — | SEC |
| 2025-07-03 | 6-K | — | SEC |
| 2025-07-03 | 6-K | — | SEC |
| 2025-05-16 | 6-K | — | SEC |
| 2025-04-28 | 6-K | CURRENT REPORT OF FOREIGN ISSUER | SEC |
| 2025-01-06 | 6-K | — | SEC |
| 2024-12-05 | 6-K | — | SEC |
| 2024-11-20 | 6-K | — | SEC |
| 2024-10-07 | 6-K | — | SEC |
| 2024-10-03 | 6-K | — | SEC |
| 2024-09-30 | 6-K | — | SEC |
| 2024-06-20 | 6-K | — | SEC |
| 2024-05-24 | 6-K | — | SEC |
| 2024-04-24 | 6-K | — | SEC |
| 2024-03-18 | 6-K | — | SEC |
| 2024-03-04 | 6-K | — | SEC |
| 2024-01-29 | 6-K | — | SEC |
出典は SEC EDGAR の 8-K／6-K。8-K は米国内企業の臨時報告（Item 2.02 が決算発表）、6-K は外国企業（ADR 含む）の対応様式です。当サイトはリンクの整理のみ行い、原文はすべて sec.gov にあります。